Control group | Intervention group | |||||
---|---|---|---|---|---|---|
Measure | Phase | Mean ± SD | Mean ± SD | Partial Eta Squared | P-Value | F |
Y-BOCS | Week 0 | 28.857 ± 7.262 | 31.600 ± 3.832 | 0.82* | < 0.001 | 60.97 |
Week 12 | 21.785 ± 7.223 | 18.866 ± 4.068 | ||||
3 months Follow-up | 23.857 ± 6.780 | 19.266 ± 3.863 | ||||
Compulsion subscale | Week 0 | 13.785 ± 4.353 | 15.400 ± 2.501 | 0.69* | < 0.001 | 29.57 |
Week 12 | 10.428 ± 4.669 | 9.266 ± 2.086 | ||||
3 months Follow-up | 11.357 ± 4.307 | 9.600 ± 2.229 | ||||
Obsession subscale | Week 0 | 15.071 ± 3.496 | 16.200 ± 2.144 | 0.61* | < 0.001 | 20.46 |
Week 12 | 11.357 ± 3.053 | 9.600 ± 2.557 | ||||
3 months Follow-up | 12.500 ± 3.228 | 9.666 ± 2.160 | ||||
BDI-II | Week 0 | 19.857 ± 3.438 | 31.133 ± 36.627 | 0.02 | 0.47 | 0.54 |
Week 12 | 16.714 ± 3.625 | 25.200 ± 24.442 | ||||
3 months Follow-up | 16.928 ± 3.832 | 25.933 ± 23.398 | ||||
BAI | Week 0 | 37.928 ± 15.137 | 39.266 ± 10.552 | 0.19 | 0.06 | 3.12 |
Week 12 | 28.285 ± 13.974 | 26.533 ± 5.998 | ||||
3 months Follow-up | 29.357 ± 13.859 | 26.466 ± 5.853 | ||||
OBQ-44 | Week 0 | 178.357 ± 30.114 | 184.133 ± 25.178 | 0.56* | < 0.001 | 16.78 |
Week 12 | 141.571 ± 29.016 | 130.266 ± 19.199 | ||||
3 months Follow-up | 141.428 ± 27.968 | 129.066 ± 19.177 | ||||
WHODAS-2 | Week 0 | 103.642 ± 28.489 | 111.800 ± 32.509 | 0.53* | < 0.001 | 14.64 |
Week 12 | 88.500 ± 27.317 | 89.866 ± 30.828 | ||||
3 months Follow-up | 93.428 ± 26.920 | 90.466 ± 30.220 |